Retirement Planning Company of New England’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
17,757
-1,296
| -7% | -$40.9K | 0.25% | 116 |
|
|
2025
Q1 | $624K | Sell |
19,053
-2,374
| -11% | -$77.7K | 0.31% | 99 |
|
|
2024
Q4 | $775K | Sell |
21,427
-1,016
| -5% | -$36.7K | 0.38% | 76 |
|
|
2024
Q3 | $700K | Sell |
22,443
-1,127
| -5% | -$35.1K | 0.35% | 86 |
|
|
2024
Q2 | $630K | Sell |
23,570
-1,934
| -8% | -$51.7K | 0.34% | 87 |
|
|
2024
Q1 | $870K | Sell |
25,504
-25,799
| -50% | -$880K | 0.48% | 66 |
|
|
2023
Q4 | $1.48M | Sell |
51,303
-305
| -0.6% | -$8.83K | 0.67% | 38 |
|
|
2023
Q3 | $1.42M | Buy |
51,608
+23,656
| +85% | +$652K | 0.79% | 32 |
|
|
2023
Q2 | $840K | Sell |
27,952
-2,625
| -9% | -$78.9K | 0.48% | 65 |
|
|
2023
Q1 | $1.11M | Sell |
30,577
-2,262
| -7% | -$82K | 0.67% | 43 |
|
|
2022
Q4 | $1.17M | Sell |
32,839
-405
| -1% | -$14.4K | 0.76% | 36 |
|
|
2022
Q3 | $1.13M | Sell |
33,244
-4,050
| -11% | -$137K | 0.81% | 30 |
|
|
2022
Q2 | $1.08M | Sell |
37,294
-675
| -2% | -$19.5K | 0.74% | 36 |
|
|
2022
Q1 | $1.23M | Buy |
37,969
+488
| +1% | +$15.8K | 0.69% | 35 |
|
|
2021
Q4 | $1.09M | Buy |
+37,481
| New | +$1.09M | 0.53% | 42 |
|